Literature DB >> 20932858

Intraplantar injection of bergamot essential oil induces peripheral antinociception mediated by opioid mechanism.

Tsukasa Sakurada1, Hirokazu Mizoguchi, Hikari Kuwahata, Soh Katsuyama, Takaaki Komatsu, Luigi Antonio Morrone, Maria Tiziana Corasaniti, Giacinto Bagetta, Shinobu Sakurada.   

Abstract

This study investigated the effect of bergamot essential oil (BEO) containing linalool and linalyl acetate as major volatile components in the capsaicin test. The intraplantar injection of capsaicin (1.6 μg) produced a short-lived licking/biting response toward the injected paw. The nociceptive behavioral response evoked by capsaicin was inhibited dose-dependently by intraplantar injection of BEO. Both linalool and linalyl acetate, injected into the hindpaw, showed a significant reduction of nociceptive response, which was much more potent than BEO. Intraperitoneal (i.p.) and intraplantar pretreatment with naloxone hydrochloride, an opioid receptor antagonist, significantly reversed BEO- and linalool-induced antinociception. Pretreatment with naloxone methiodide, a peripherally acting μ-opioid receptor preferring antagonist, resulted in a significant antagonizing effect on antinociception induced by BEO and linalool. Antinociception induced by i.p. or intrathecal morphine was enhanced by the combined injection of BEO or linalool. The enhanced effect of combination of BEO or linalool with morphine was antagonized by pretreatment with naloxone hydrochloride. Our results provide evidence for the involvement of peripheral opioids, in the antinociception induced by BEO and linalool. Combined administration of BEO or linalool acting at the peripheral site, and morphine may be a promising approach in the treatment of clinical pain.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20932858     DOI: 10.1016/j.pbb.2010.09.020

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  25 in total

1.  Linalool and linalool complexed in β-cyclodextrin produce anti-hyperalgesic activity and increase Fos protein expression in animal model for fibromyalgia.

Authors:  Simone S Nascimento; Enilton A Camargo; Josimari M DeSantana; Adriano A S Araújo; Paula P Menezes; Waldecy Lucca-Júnior; Ricardo L C Albuquerque-Júnior; Leonardo R Bonjardim; Lucindo J Quintans-Júnior
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-06-24       Impact factor: 3.000

Review 2.  Mouse models of acute, chemical itch and pain in humans.

Authors:  Robert H LaMotte; Steven G Shimada; Parul Sikand
Journal:  Exp Dermatol       Date:  2011-10       Impact factor: 3.960

3.  Effect of Experimental Gestational Diabetes Mellitus on Mechanical Sensitivity, Capsaicin-Induced Pain Behaviors and Hind Paw Glabrous Skin Innervation of Male and Female Mouse Offspring.

Authors:  Enriqueta Munoz-Islas; Cecilia Esther Elizondo-Martinez; Mariela Gutierrez-Lopez; Rosa Issel Acosta-Gonzalez; Veronica Zaga-Clavellina; Addy Cecilia Helguera-Repetto; Martha Beatriz Ramirez-Rosas; E Alfonso Romero-Sandoval; Juan Miguel Jimenez-Andrade
Journal:  J Pain Res       Date:  2021-06-02       Impact factor: 3.133

4.  Cyclodextrin-complexed Ocimum basilicum leaves essential oil increases Fos protein expression in the central nervous system and produce an antihyperalgesic effect in animal models for fibromyalgia.

Authors:  Simone S Nascimento; Adriano A S Araújo; Renan G Brito; Mairim R Serafini; Paula P Menezes; Josimari M DeSantana; Waldecy Lucca; Pericles B Alves; Arie F Blank; Rita C M Oliveira; Aldeidia P Oliveira; Ricardo L C Albuquerque; Jackson R G S Almeida; Lucindo J Quintans
Journal:  Int J Mol Sci       Date:  2014-12-29       Impact factor: 5.923

Review 5.  Citrus bergamia essential oil: from basic research to clinical application.

Authors:  Michele Navarra; Carmen Mannucci; Marisa Delbò; Gioacchino Calapai
Journal:  Front Pharmacol       Date:  2015-03-02       Impact factor: 5.810

6.  Nerve demyelination increases metabotropic glutamate receptor subtype 5 expression in peripheral painful mononeuropathy.

Authors:  Miau-Hwa Ko; Yu-Lin Hsieh; Sung-Tsang Hsieh; To-Jung Tseng
Journal:  Int J Mol Sci       Date:  2015-03-02       Impact factor: 5.923

Review 7.  Exploitation of cytotoxicity of some essential oils for translation in cancer therapy.

Authors:  Rossella Russo; Maria Tiziana Corasaniti; Giacinto Bagetta; Luigi Antonio Morrone
Journal:  Evid Based Complement Alternat Med       Date:  2015-02-04       Impact factor: 2.629

8.  Development and Translation of NanoBEO, a Nanotechnology-Based Delivery System of Bergamot Essential Oil Deprived of Furocumarins, in the Control of Agitation in Severe Dementia.

Authors:  Damiana Scuteri; Roberta Cassano; Sonia Trombino; Rossella Russo; Hirokazu Mizoguchi; Chizuko Watanabe; Kengo Hamamura; Soh Katsuyama; Takaaki Komatsu; Luigi Antonio Morrone; Laura Rombolà; Annagrazia Adornetto; Annarita S Laganà; Maria Tiziana Corasaniti; Paolo Tonin; Shinobu Sakurada; Tsukasa Sakurada; Pierluigi Nicotera; Giacinto Bagetta
Journal:  Pharmaceutics       Date:  2021-03-12       Impact factor: 6.321

9.  Citrus bergamia Risso Elevates Intracellular Ca (2+) in Human Vascular Endothelial Cells due to Release of Ca (2+) from Primary Intracellular Stores.

Authors:  Purum Kang; Seung Ho Han; Hea Kyung Moon; Jeong-Min Lee; Hyo-Keun Kim; Sun Seek Min; Geun Hee Seol
Journal:  Evid Based Complement Alternat Med       Date:  2013-11-21       Impact factor: 2.629

10.  Bergamot Reduces Plasma Lipids, Atherogenic Small Dense LDL, and Subclinical Atherosclerosis in Subjects with Moderate Hypercholesterolemia: A 6 Months Prospective Study.

Authors:  Peter P Toth; Angelo M Patti; Dragana Nikolic; Rosaria V Giglio; Giuseppa Castellino; Teresa Biancucci; Fabiana Geraci; Sabrina David; Giuseppe Montalto; Ali Rizvi; Manfredi Rizzo
Journal:  Front Pharmacol       Date:  2016-01-06       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.